coronavirus vaccine

COVID-19: The Push for a Vaccine

Join us for Episode 4 of GEN Live, sponsored by Tecan. In this live zoom event we discuss the state of vaccine development for COVID-19. We evaluate the front-runners, explore the potential of RNA vaccines, ponder the challenges of manufacturing, and tackle questions about herd immunity.

A CRISPR Vision for the Future of Cell Therapy

In this webinar from GEN and The CRISPR Journal, T.J. Cradick, PhD, —who was until recently head of genome editing at CRISPR Therapeutics—will introduce how genome editing is used to engineer cell therapies.

Gene Therapy: What’s Up With AAV?

In this recorded GEN Live event, sponsored by PerkinElmer, we discussed the state of gene therapy, the rise of AAV, and the safety issues that need to be addressed going forward.
GenScript Webinar lead image

Improving Plasmid and Viral Vectors in Cell and Gene Therapy

In this GEN webinar, we will hear how GenScript ProBio aids the biopharma industry as it continues to develop and optimize processes for GMP plasmids, lenti, and AAV viral vector manufacturing.

Nip, Tuck, CRISPR: Gene Editing Could Give Plastic Surgery a Lift

Cleft palates. Grievous wounds. Lost hands or faces. All could be repaired more completely than is currently possible if genetic editing were to become...

Synthego Eyes Product, Platform Expansions with Latest $110M Financing

Synthego says the $110 million in Series C financing it raised this week will enable it to proceed with ambitious expansion plans that include...
Bacteriophage Infecting Bacterium

CRISPR Defense Thwarted through Viral Cooperation

Virus particles that infect bacteria can work together to overcome antiviral defences, new research shows.
Mechanism Schematic

Novel Nano System Delivers mRNA to Inflammatory Leukocytes

Team uses mRNA-loaded carriers to target the genetic instructions of an anti-inflammatory protein in immune cells.
Source: WikiCommons

CRISPR Method Dramatically Improves Gene Editing Delivery to Mosquitoes

A technology designed to improve CRISPR-Cas9 gene editing in mosquitoes and other arthropods succeeds with a high degree of efficiency, while eliminating the need for difficult microinjection of genetic material, according to researchers.
The left-side group of mice is a control—with neither the gene-editing RNA nor the BOC switch. The next group has BOC but no RNA

Biological Switch May Offer Better Control of Gene Editing

Team invents biological switch that turns protein expression on at will